.png)
Agenzia Italiana del Farmaco
home
Highlights
-
27 Feb 2026
Press releases
AIFA supports the Rare Disease Day 2026
AIFA headquarters will be illuminated with the colours symbolizing the initiative on February 28 - Rare Disease Day, in order to shine a spotlight on a reality that cannot remain invisible.
-
26 Feb 2026
Press releases
Duchenne and multiple myeloma: the NHS reimburses two innovative therapies
AIFA Board of Directors Approves 6 new medicines (4 for rare diseases) and new indications in oncology.
-
23 Feb 2026
Press releases
From “one-size-fits-all” medicine to tailored treatments
AIFA publishes Position Paper on precision medicine and appropriate prescriptions.
-
09 Feb 2026
Press releases
Memorandum of Understanding between AIFA and NADO (National Anti-Doping Organisation)
The Italian Medicines Agency provides NADO with information on doping medicines authorised in Italy, extracted from its database, for the creation of a platform dedicated to athletes.
News
24 Feb 2026
Lists of Class A and Class H medicinal products
List of class A and H medicinal products at 30 September 2025
23 Feb 2026
Medicinal product supply regime
New guidelines on the definition and classification of OTC and SOP medicines
18 Feb 2026
Monitoring pharmaceutical expenditure
Biosimilar medicines in Italy: AIFA reports updated
17 Feb 2026
Access to medicinal products
Textile Supplementary Series for patch tests
16 Feb 2026
Transparency Lists
AIFA updates the Transparency Lists
13 Feb 2026
Safety of medicinal products
Meeting highlights from the Pharmacovigilance Risk Assessment Committee (PRAC) 9-12 February 2026
FarmaciLine
Questions regarding drug efficacy, safety and availability
TOLL-FREE NUMBER
Services
Interactive OsMed - The use of medicines in Italy
An interactive consultation of data on the use of medicines in Italy in the general and regional population, described in terms of expenditure, volumes, typology
Media
